Replies to post #329365 on Amarin Corp Plc (AMRN)

[Number sleven]

Raf, Thanks. Good numbers. Nice to see the gv drop.
Sleven,

[ggwpq]

Thanks Raf, MVPoster.

[Examiner77]

Thank you Raf
Scripts numbers are picking up over the last two weeks, lets hope this will be the new trend

[MA52TA]

THANKS RAF.

[Invest83838]

Thank You Raf - Was GV increase large positive last week

and now large negative this week?

If so, still seems like there is a weekly up & down trend with GV

as if part of it is only being reported every other week

[ralphey]

IS this the off week for gV?

[CaptBeer]

Total Scripts and Market Shares WE 3/5/21:

[luvbio]

Thanks Raf, considering that most patients are still not seeing their docs, I think we're doing all right.

[circuitcity]

Thank you for the scripts.


The way I read the script:

1) maybe the gV threat is over stated (has been below 10% consistently because of shatter reasons: on purpose? Or supply? Don’t know)

2) but the bigger issue now is the ability of amrn to grow the market, JT failed to grow the market at all, evidenced by the total of amrn and gV has been basically flat. I hope people and bod can see how bad the gia strategy is by now and accept whatever bo they can get.

3) rev of gL has been pretty much flat as well, but they spent nothing on sales and marketing.

[rafunrafun]

Sripts for week ending March 12, 2021:

Over the entire industry, drug TRx are -1.6% w/w.

Vascepa
TRx 83,863; -3.5% w/w; -3.8% y/y
NRx 39,601; -3.2% w/w; -5.8% y/y
Ref 44,262; -3.9% w/w; -1.8% y/y

Generic Vascepa
TRx 9,531; +19.2% w/w; As % of total V: 10.2%
NRx 5,543; +18.9% w/w; As % of total V: 12.3%
Ref 3,989; +19.6% w/w; As % of total V: 8.3%

Lovaza (Generic & Brand)
TRx 62,953; -1.1% w/w; +1.6% y/y
NRx 32,143; -0.7% w/w; +6.4% y/y
Ref 30,811; -1.5% w/w; -2.9% y/y